EYA3 and Miyoshi myopathy: Thus, our primary MM sample proteomics and image-based drug screening results could be recapitulated in transcriptomics and bulk-drug screening results on MM-derived cell lines, further supporting a role for both DEPTOR and EYA3 as regulators of bortezomib sensitivity in MM.